nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—kidney cancer	0.367	1	CbGaD
Hydromorphone—UGT1A9—Sorafenib—kidney cancer	0.0828	0.217	CbGbCtD
Hydromorphone—CYP2D6—Temsirolimus—kidney cancer	0.0415	0.109	CbGbCtD
Hydromorphone—CYP3A4—Everolimus—kidney cancer	0.0391	0.102	CbGbCtD
Hydromorphone—CYP3A4—Temsirolimus—kidney cancer	0.0264	0.0691	CbGbCtD
Hydromorphone—CYP2C9—Capecitabine—kidney cancer	0.0249	0.0651	CbGbCtD
Hydromorphone—CYP2D6—Pazopanib—kidney cancer	0.0218	0.057	CbGbCtD
Hydromorphone—CYP2C9—Paclitaxel—kidney cancer	0.0156	0.0408	CbGbCtD
Hydromorphone—CYP2D6—Erlotinib—kidney cancer	0.0156	0.0407	CbGbCtD
Hydromorphone—CYP3A4—Pazopanib—kidney cancer	0.0139	0.0363	CbGbCtD
Hydromorphone—CYP2C9—Sorafenib—kidney cancer	0.0138	0.0362	CbGbCtD
Hydromorphone—CYP2D6—Sorafenib—kidney cancer	0.0127	0.0331	CbGbCtD
Hydromorphone—CYP2D6—Vinblastine—kidney cancer	0.0125	0.0327	CbGbCtD
Hydromorphone—CYP3A4—Erlotinib—kidney cancer	0.0099	0.0259	CbGbCtD
Hydromorphone—CYP3A4—Paclitaxel—kidney cancer	0.00906	0.0237	CbGbCtD
Hydromorphone—CYP3A4—Sorafenib—kidney cancer	0.00805	0.021	CbGbCtD
Hydromorphone—CYP3A4—Vinblastine—kidney cancer	0.00795	0.0208	CbGbCtD
Hydromorphone—CYP3A4—Vincristine—kidney cancer	0.00782	0.0204	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—kidney cancer	0.00768	0.0201	CbGbCtD
Hydromorphone—CYP3A4—Sunitinib—kidney cancer	0.00652	0.0171	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—kidney cancer	0.00488	0.0128	CbGbCtD
Hydromorphone—CYP2C9—urine—kidney cancer	0.00102	0.145	CbGeAlD
Hydromorphone—UGT1A9—renal system—kidney cancer	0.000863	0.124	CbGeAlD
Hydromorphone—UGT1A9—kidney—kidney cancer	0.000834	0.119	CbGeAlD
Hydromorphone—CYP3A4—urine—kidney cancer	0.000774	0.111	CbGeAlD
Hydromorphone—CYP2D6—urine—kidney cancer	0.000762	0.109	CbGeAlD
Hydromorphone—OPRD1—renal system—kidney cancer	0.000682	0.0977	CbGeAlD
Hydromorphone—OPRD1—kidney—kidney cancer	0.000659	0.0944	CbGeAlD
Hydromorphone—PTGS1—renal system—kidney cancer	0.000227	0.0325	CbGeAlD
Hydromorphone—PTGS1—kidney—kidney cancer	0.000219	0.0314	CbGeAlD
Hydromorphone—PTGS1—cardiac atrium—kidney cancer	0.000203	0.0291	CbGeAlD
Hydromorphone—CYP3A4—renal system—kidney cancer	0.000189	0.0271	CbGeAlD
Hydromorphone—CYP2D6—renal system—kidney cancer	0.000186	0.0267	CbGeAlD
Hydromorphone—CYP3A4—kidney—kidney cancer	0.000183	0.0262	CbGeAlD
Hydromorphone—CYP2D6—kidney—kidney cancer	0.00018	0.0258	CbGeAlD
Hydromorphone—Decreased appetite—Gemcitabine—kidney cancer	8.15e-05	0.000375	CcSEcCtD
Hydromorphone—Hypersensitivity—Dactinomycin—kidney cancer	8.14e-05	0.000375	CcSEcCtD
Hydromorphone—Chills—Capecitabine—kidney cancer	8.13e-05	0.000374	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	8.13e-05	0.000374	CcSEcCtD
Hydromorphone—Arrhythmia—Capecitabine—kidney cancer	8.09e-05	0.000372	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Gemcitabine—kidney cancer	8.09e-05	0.000372	CcSEcCtD
Hydromorphone—Discomfort—Paclitaxel—kidney cancer	8.09e-05	0.000372	CcSEcCtD
Hydromorphone—Fatigue—Gemcitabine—kidney cancer	8.08e-05	0.000371	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Vincristine—kidney cancer	8.08e-05	0.000371	CcSEcCtD
Hydromorphone—Cardiac arrest—Doxorubicin—kidney cancer	8.03e-05	0.000369	CcSEcCtD
Hydromorphone—Dizziness—Sorafenib—kidney cancer	8.02e-05	0.000369	CcSEcCtD
Hydromorphone—Constipation—Gemcitabine—kidney cancer	8.01e-05	0.000368	CcSEcCtD
Hydromorphone—Pain—Gemcitabine—kidney cancer	8.01e-05	0.000368	CcSEcCtD
Hydromorphone—Nausea—Erlotinib—kidney cancer	8.01e-05	0.000368	CcSEcCtD
Hydromorphone—Dry mouth—Paclitaxel—kidney cancer	8e-05	0.000368	CcSEcCtD
Hydromorphone—Mood swings—Doxorubicin—kidney cancer	8e-05	0.000368	CcSEcCtD
Hydromorphone—Diarrhoea—Sunitinib—kidney cancer	7.99e-05	0.000367	CcSEcCtD
Hydromorphone—Mental disorder—Capecitabine—kidney cancer	7.94e-05	0.000365	CcSEcCtD
Hydromorphone—Asthenia—Dactinomycin—kidney cancer	7.93e-05	0.000365	CcSEcCtD
Hydromorphone—Confusional state—Paclitaxel—kidney cancer	7.91e-05	0.000364	CcSEcCtD
Hydromorphone—Erythema—Capecitabine—kidney cancer	7.89e-05	0.000363	CcSEcCtD
Hydromorphone—Malnutrition—Capecitabine—kidney cancer	7.89e-05	0.000363	CcSEcCtD
Hydromorphone—Dehydration—Doxorubicin—kidney cancer	7.85e-05	0.000361	CcSEcCtD
Hydromorphone—Anaphylactic shock—Paclitaxel—kidney cancer	7.84e-05	0.000361	CcSEcCtD
Hydromorphone—Body temperature increased—Vincristine—kidney cancer	7.81e-05	0.000359	CcSEcCtD
Hydromorphone—Abdominal pain—Vincristine—kidney cancer	7.81e-05	0.000359	CcSEcCtD
Hydromorphone—Infection—Paclitaxel—kidney cancer	7.79e-05	0.000358	CcSEcCtD
Hydromorphone—Flatulence—Capecitabine—kidney cancer	7.77e-05	0.000357	CcSEcCtD
Hydromorphone—Dysgeusia—Capecitabine—kidney cancer	7.72e-05	0.000355	CcSEcCtD
Hydromorphone—Dizziness—Sunitinib—kidney cancer	7.72e-05	0.000355	CcSEcCtD
Hydromorphone—Feeling abnormal—Gemcitabine—kidney cancer	7.72e-05	0.000355	CcSEcCtD
Hydromorphone—Shock—Paclitaxel—kidney cancer	7.72e-05	0.000355	CcSEcCtD
Hydromorphone—Vomiting—Sorafenib—kidney cancer	7.72e-05	0.000355	CcSEcCtD
Hydromorphone—Abdominal pain upper—Doxorubicin—kidney cancer	7.71e-05	0.000355	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Doxorubicin—kidney cancer	7.71e-05	0.000355	CcSEcCtD
Hydromorphone—Nervous system disorder—Paclitaxel—kidney cancer	7.69e-05	0.000354	CcSEcCtD
Hydromorphone—Tachycardia—Paclitaxel—kidney cancer	7.66e-05	0.000352	CcSEcCtD
Hydromorphone—Rash—Sorafenib—kidney cancer	7.65e-05	0.000352	CcSEcCtD
Hydromorphone—Dermatitis—Sorafenib—kidney cancer	7.64e-05	0.000352	CcSEcCtD
Hydromorphone—Back pain—Capecitabine—kidney cancer	7.63e-05	0.000351	CcSEcCtD
Hydromorphone—Breast disorder—Doxorubicin—kidney cancer	7.63e-05	0.000351	CcSEcCtD
Hydromorphone—Skin disorder—Paclitaxel—kidney cancer	7.62e-05	0.00035	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	7.6e-05	0.00035	CcSEcCtD
Hydromorphone—Headache—Sorafenib—kidney cancer	7.6e-05	0.00035	CcSEcCtD
Hydromorphone—Muscle spasms—Capecitabine—kidney cancer	7.58e-05	0.000349	CcSEcCtD
Hydromorphone—Hyperhidrosis—Paclitaxel—kidney cancer	7.58e-05	0.000349	CcSEcCtD
Hydromorphone—Diarrhoea—Dactinomycin—kidney cancer	7.56e-05	0.000348	CcSEcCtD
Hydromorphone—Nasopharyngitis—Doxorubicin—kidney cancer	7.55e-05	0.000347	CcSEcCtD
Hydromorphone—Anorexia—Paclitaxel—kidney cancer	7.48e-05	0.000344	CcSEcCtD
Hydromorphone—Gastritis—Doxorubicin—kidney cancer	7.47e-05	0.000344	CcSEcCtD
Hydromorphone—Muscular weakness—Doxorubicin—kidney cancer	7.45e-05	0.000342	CcSEcCtD
Hydromorphone—Vision blurred—Capecitabine—kidney cancer	7.43e-05	0.000342	CcSEcCtD
Hydromorphone—Vomiting—Sunitinib—kidney cancer	7.42e-05	0.000341	CcSEcCtD
Hydromorphone—Body temperature increased—Gemcitabine—kidney cancer	7.41e-05	0.000341	CcSEcCtD
Hydromorphone—Tremor—Capecitabine—kidney cancer	7.39e-05	0.00034	CcSEcCtD
Hydromorphone—Rash—Sunitinib—kidney cancer	7.36e-05	0.000339	CcSEcCtD
Hydromorphone—Dermatitis—Sunitinib—kidney cancer	7.36e-05	0.000338	CcSEcCtD
Hydromorphone—Abdominal distension—Doxorubicin—kidney cancer	7.35e-05	0.000338	CcSEcCtD
Hydromorphone—Hypotension—Paclitaxel—kidney cancer	7.33e-05	0.000337	CcSEcCtD
Hydromorphone—Ill-defined disorder—Capecitabine—kidney cancer	7.32e-05	0.000337	CcSEcCtD
Hydromorphone—Headache—Sunitinib—kidney cancer	7.32e-05	0.000336	CcSEcCtD
Hydromorphone—Asthma—Doxorubicin—kidney cancer	7.3e-05	0.000336	CcSEcCtD
Hydromorphone—Dysphagia—Doxorubicin—kidney cancer	7.3e-05	0.000336	CcSEcCtD
Hydromorphone—Hypersensitivity—Vincristine—kidney cancer	7.28e-05	0.000335	CcSEcCtD
Hydromorphone—Nausea—Sorafenib—kidney cancer	7.21e-05	0.000331	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.15e-05	0.000329	CcSEcCtD
Hydromorphone—Malaise—Capecitabine—kidney cancer	7.11e-05	0.000327	CcSEcCtD
Hydromorphone—Insomnia—Paclitaxel—kidney cancer	7.1e-05	0.000326	CcSEcCtD
Hydromorphone—Vertigo—Capecitabine—kidney cancer	7.09e-05	0.000326	CcSEcCtD
Hydromorphone—Asthenia—Vincristine—kidney cancer	7.09e-05	0.000326	CcSEcCtD
Hydromorphone—Syncope—Capecitabine—kidney cancer	7.07e-05	0.000325	CcSEcCtD
Hydromorphone—Leukopenia—Capecitabine—kidney cancer	7.06e-05	0.000325	CcSEcCtD
Hydromorphone—Paraesthesia—Paclitaxel—kidney cancer	7.04e-05	0.000324	CcSEcCtD
Hydromorphone—Vomiting—Dactinomycin—kidney cancer	7.03e-05	0.000323	CcSEcCtD
Hydromorphone—Dyspnoea—Paclitaxel—kidney cancer	6.99e-05	0.000322	CcSEcCtD
Hydromorphone—Somnolence—Paclitaxel—kidney cancer	6.97e-05	0.000321	CcSEcCtD
Hydromorphone—Palpitations—Capecitabine—kidney cancer	6.97e-05	0.000321	CcSEcCtD
Hydromorphone—Rash—Dactinomycin—kidney cancer	6.97e-05	0.000321	CcSEcCtD
Hydromorphone—Nausea—Sunitinib—kidney cancer	6.94e-05	0.000319	CcSEcCtD
Hydromorphone—Loss of consciousness—Capecitabine—kidney cancer	6.93e-05	0.000319	CcSEcCtD
Hydromorphone—Dyspepsia—Paclitaxel—kidney cancer	6.91e-05	0.000318	CcSEcCtD
Hydromorphone—Cough—Capecitabine—kidney cancer	6.88e-05	0.000317	CcSEcCtD
Hydromorphone—Dysuria—Doxorubicin—kidney cancer	6.82e-05	0.000314	CcSEcCtD
Hydromorphone—Decreased appetite—Paclitaxel—kidney cancer	6.82e-05	0.000314	CcSEcCtD
Hydromorphone—Hypertension—Capecitabine—kidney cancer	6.81e-05	0.000313	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.77e-05	0.000311	CcSEcCtD
Hydromorphone—Fatigue—Paclitaxel—kidney cancer	6.76e-05	0.000311	CcSEcCtD
Hydromorphone—Diarrhoea—Vincristine—kidney cancer	6.76e-05	0.000311	CcSEcCtD
Hydromorphone—Pollakiuria—Doxorubicin—kidney cancer	6.74e-05	0.00031	CcSEcCtD
Hydromorphone—Asthenia—Gemcitabine—kidney cancer	6.72e-05	0.000309	CcSEcCtD
Hydromorphone—Arthralgia—Capecitabine—kidney cancer	6.72e-05	0.000309	CcSEcCtD
Hydromorphone—Chest pain—Capecitabine—kidney cancer	6.72e-05	0.000309	CcSEcCtD
Hydromorphone—Myalgia—Capecitabine—kidney cancer	6.72e-05	0.000309	CcSEcCtD
Hydromorphone—Constipation—Paclitaxel—kidney cancer	6.71e-05	0.000308	CcSEcCtD
Hydromorphone—Pain—Paclitaxel—kidney cancer	6.71e-05	0.000308	CcSEcCtD
Hydromorphone—Anxiety—Capecitabine—kidney cancer	6.69e-05	0.000308	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.67e-05	0.000307	CcSEcCtD
Hydromorphone—Discomfort—Capecitabine—kidney cancer	6.64e-05	0.000305	CcSEcCtD
Hydromorphone—Pruritus—Gemcitabine—kidney cancer	6.63e-05	0.000305	CcSEcCtD
Hydromorphone—Weight decreased—Doxorubicin—kidney cancer	6.6e-05	0.000304	CcSEcCtD
Hydromorphone—Dry mouth—Capecitabine—kidney cancer	6.57e-05	0.000302	CcSEcCtD
Hydromorphone—Nausea—Dactinomycin—kidney cancer	6.57e-05	0.000302	CcSEcCtD
Hydromorphone—Dizziness—Vincristine—kidney cancer	6.53e-05	0.0003	CcSEcCtD
Hydromorphone—Infestation—Doxorubicin—kidney cancer	6.51e-05	0.000299	CcSEcCtD
Hydromorphone—Infestation NOS—Doxorubicin—kidney cancer	6.51e-05	0.000299	CcSEcCtD
Hydromorphone—Drowsiness—Doxorubicin—kidney cancer	6.51e-05	0.000299	CcSEcCtD
Hydromorphone—Confusional state—Capecitabine—kidney cancer	6.49e-05	0.000299	CcSEcCtD
Hydromorphone—Feeling abnormal—Paclitaxel—kidney cancer	6.46e-05	0.000297	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Paclitaxel—kidney cancer	6.41e-05	0.000295	CcSEcCtD
Hydromorphone—Diarrhoea—Gemcitabine—kidney cancer	6.41e-05	0.000295	CcSEcCtD
Hydromorphone—Infection—Capecitabine—kidney cancer	6.4e-05	0.000294	CcSEcCtD
Hydromorphone—Stomatitis—Doxorubicin—kidney cancer	6.34e-05	0.000292	CcSEcCtD
Hydromorphone—Shock—Capecitabine—kidney cancer	6.33e-05	0.000291	CcSEcCtD
Hydromorphone—Nervous system disorder—Capecitabine—kidney cancer	6.31e-05	0.00029	CcSEcCtD
Hydromorphone—Tachycardia—Capecitabine—kidney cancer	6.28e-05	0.000289	CcSEcCtD
Hydromorphone—Vomiting—Vincristine—kidney cancer	6.28e-05	0.000289	CcSEcCtD
Hydromorphone—Skin disorder—Capecitabine—kidney cancer	6.25e-05	0.000288	CcSEcCtD
Hydromorphone—Sweating—Doxorubicin—kidney cancer	6.24e-05	0.000287	CcSEcCtD
Hydromorphone—Urticaria—Paclitaxel—kidney cancer	6.23e-05	0.000287	CcSEcCtD
Hydromorphone—Rash—Vincristine—kidney cancer	6.23e-05	0.000286	CcSEcCtD
Hydromorphone—Hyperhidrosis—Capecitabine—kidney cancer	6.22e-05	0.000286	CcSEcCtD
Hydromorphone—Dermatitis—Vincristine—kidney cancer	6.22e-05	0.000286	CcSEcCtD
Hydromorphone—Abdominal pain—Paclitaxel—kidney cancer	6.2e-05	0.000285	CcSEcCtD
Hydromorphone—Body temperature increased—Paclitaxel—kidney cancer	6.2e-05	0.000285	CcSEcCtD
Hydromorphone—Headache—Vincristine—kidney cancer	6.19e-05	0.000285	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Doxorubicin—kidney cancer	6.15e-05	0.000283	CcSEcCtD
Hydromorphone—Anorexia—Capecitabine—kidney cancer	6.14e-05	0.000282	CcSEcCtD
Hydromorphone—Hypotension—Capecitabine—kidney cancer	6.02e-05	0.000277	CcSEcCtD
Hydromorphone—Vomiting—Gemcitabine—kidney cancer	5.96e-05	0.000274	CcSEcCtD
Hydromorphone—Bradycardia—Doxorubicin—kidney cancer	5.95e-05	0.000273	CcSEcCtD
Hydromorphone—Rash—Gemcitabine—kidney cancer	5.91e-05	0.000272	CcSEcCtD
Hydromorphone—Dermatitis—Gemcitabine—kidney cancer	5.9e-05	0.000271	CcSEcCtD
Hydromorphone—Headache—Gemcitabine—kidney cancer	5.87e-05	0.00027	CcSEcCtD
Hydromorphone—Nausea—Vincristine—kidney cancer	5.87e-05	0.00027	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.87e-05	0.00027	CcSEcCtD
Hydromorphone—Rhinitis—Doxorubicin—kidney cancer	5.86e-05	0.000269	CcSEcCtD
Hydromorphone—Insomnia—Capecitabine—kidney cancer	5.82e-05	0.000268	CcSEcCtD
Hydromorphone—Hypoaesthesia—Doxorubicin—kidney cancer	5.81e-05	0.000267	CcSEcCtD
Hydromorphone—Paraesthesia—Capecitabine—kidney cancer	5.78e-05	0.000266	CcSEcCtD
Hydromorphone—Hypersensitivity—Paclitaxel—kidney cancer	5.78e-05	0.000266	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—kidney cancer	5.77e-05	0.000265	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—kidney cancer	5.75e-05	0.000265	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—kidney cancer	5.74e-05	0.000264	CcSEcCtD
Hydromorphone—Dyspnoea—Capecitabine—kidney cancer	5.74e-05	0.000264	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—kidney cancer	5.73e-05	0.000263	CcSEcCtD
Hydromorphone—Dyspepsia—Capecitabine—kidney cancer	5.67e-05	0.000261	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—kidney cancer	5.63e-05	0.000259	CcSEcCtD
Hydromorphone—Asthenia—Paclitaxel—kidney cancer	5.63e-05	0.000259	CcSEcCtD
Hydromorphone—Decreased appetite—Capecitabine—kidney cancer	5.6e-05	0.000257	CcSEcCtD
Hydromorphone—Nausea—Gemcitabine—kidney cancer	5.57e-05	0.000256	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Capecitabine—kidney cancer	5.56e-05	0.000256	CcSEcCtD
Hydromorphone—Fatigue—Capecitabine—kidney cancer	5.55e-05	0.000255	CcSEcCtD
Hydromorphone—Pruritus—Paclitaxel—kidney cancer	5.55e-05	0.000255	CcSEcCtD
Hydromorphone—Pain—Capecitabine—kidney cancer	5.51e-05	0.000253	CcSEcCtD
Hydromorphone—Constipation—Capecitabine—kidney cancer	5.51e-05	0.000253	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—kidney cancer	5.46e-05	0.000251	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—kidney cancer	5.45e-05	0.00025	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—kidney cancer	5.42e-05	0.000249	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—kidney cancer	5.42e-05	0.000249	CcSEcCtD
Hydromorphone—Diarrhoea—Paclitaxel—kidney cancer	5.37e-05	0.000247	CcSEcCtD
Hydromorphone—Feeling abnormal—Capecitabine—kidney cancer	5.31e-05	0.000244	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—kidney cancer	5.3e-05	0.000244	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—kidney cancer	5.28e-05	0.000243	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Capecitabine—kidney cancer	5.26e-05	0.000242	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—kidney cancer	5.26e-05	0.000242	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—kidney cancer	5.24e-05	0.000241	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—kidney cancer	5.22e-05	0.00024	CcSEcCtD
Hydromorphone—Dizziness—Paclitaxel—kidney cancer	5.19e-05	0.000239	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—kidney cancer	5.12e-05	0.000235	CcSEcCtD
Hydromorphone—Urticaria—Capecitabine—kidney cancer	5.11e-05	0.000235	CcSEcCtD
Hydromorphone—Abdominal pain—Capecitabine—kidney cancer	5.09e-05	0.000234	CcSEcCtD
Hydromorphone—Body temperature increased—Capecitabine—kidney cancer	5.09e-05	0.000234	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—kidney cancer	5.08e-05	0.000234	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—kidney cancer	5.08e-05	0.000234	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—kidney cancer	5.01e-05	0.00023	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—kidney cancer	4.99e-05	0.000229	CcSEcCtD
Hydromorphone—Vomiting—Paclitaxel—kidney cancer	4.99e-05	0.000229	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—kidney cancer	4.98e-05	0.000229	CcSEcCtD
Hydromorphone—Rash—Paclitaxel—kidney cancer	4.95e-05	0.000227	CcSEcCtD
Hydromorphone—Dermatitis—Paclitaxel—kidney cancer	4.94e-05	0.000227	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—kidney cancer	4.94e-05	0.000227	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—kidney cancer	4.92e-05	0.000226	CcSEcCtD
Hydromorphone—Headache—Paclitaxel—kidney cancer	4.91e-05	0.000226	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—kidney cancer	4.89e-05	0.000225	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—kidney cancer	4.79e-05	0.00022	CcSEcCtD
Hydromorphone—Naltrexone—ABCB1—kidney cancer	4.75e-05	0.349	CrCbGaD
Hydromorphone—Hypersensitivity—Capecitabine—kidney cancer	4.74e-05	0.000218	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—kidney cancer	4.72e-05	0.000217	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—kidney cancer	4.67e-05	0.000215	CcSEcCtD
Hydromorphone—Nausea—Paclitaxel—kidney cancer	4.66e-05	0.000214	CcSEcCtD
Hydromorphone—Asthenia—Capecitabine—kidney cancer	4.62e-05	0.000212	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—kidney cancer	4.59e-05	0.000211	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—kidney cancer	4.57e-05	0.00021	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—kidney cancer	4.56e-05	0.00021	CcSEcCtD
Hydromorphone—Pruritus—Capecitabine—kidney cancer	4.55e-05	0.000209	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—kidney cancer	4.55e-05	0.000209	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—kidney cancer	4.49e-05	0.000207	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—kidney cancer	4.47e-05	0.000206	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—kidney cancer	4.44e-05	0.000204	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—kidney cancer	4.41e-05	0.000203	CcSEcCtD
Hydromorphone—Diarrhoea—Capecitabine—kidney cancer	4.4e-05	0.000203	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—kidney cancer	4.39e-05	0.000202	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—kidney cancer	4.33e-05	0.000199	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—kidney cancer	4.33e-05	0.000199	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—kidney cancer	4.33e-05	0.000199	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—kidney cancer	4.31e-05	0.000198	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.3e-05	0.000198	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—kidney cancer	4.28e-05	0.000197	CcSEcCtD
Hydromorphone—Dizziness—Capecitabine—kidney cancer	4.26e-05	0.000196	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—kidney cancer	4.23e-05	0.000195	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—kidney cancer	4.18e-05	0.000192	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—kidney cancer	4.15e-05	0.000191	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—kidney cancer	4.12e-05	0.00019	CcSEcCtD
Hydromorphone—Vomiting—Capecitabine—kidney cancer	4.09e-05	0.000188	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—kidney cancer	4.08e-05	0.000188	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—kidney cancer	4.07e-05	0.000187	CcSEcCtD
Hydromorphone—Rash—Capecitabine—kidney cancer	4.06e-05	0.000187	CcSEcCtD
Hydromorphone—Dermatitis—Capecitabine—kidney cancer	4.06e-05	0.000186	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—kidney cancer	4.05e-05	0.000186	CcSEcCtD
Hydromorphone—Headache—Capecitabine—kidney cancer	4.03e-05	0.000185	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—kidney cancer	4.03e-05	0.000185	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—kidney cancer	4.01e-05	0.000184	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—kidney cancer	3.96e-05	0.000182	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—kidney cancer	3.88e-05	0.000178	CcSEcCtD
Hydromorphone—Nausea—Capecitabine—kidney cancer	3.82e-05	0.000176	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.78e-05	0.000174	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—kidney cancer	3.75e-05	0.000173	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—kidney cancer	3.73e-05	0.000171	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—kidney cancer	3.7e-05	0.00017	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—kidney cancer	3.69e-05	0.00017	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—kidney cancer	3.65e-05	0.000168	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—kidney cancer	3.61e-05	0.000166	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.58e-05	0.000165	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—kidney cancer	3.58e-05	0.000165	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—kidney cancer	3.55e-05	0.000163	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—kidney cancer	3.55e-05	0.000163	CcSEcCtD
Hydromorphone—Naloxone—ABCB1—kidney cancer	3.46e-05	0.255	CrCbGaD
Hydromorphone—Feeling abnormal—Doxorubicin—kidney cancer	3.42e-05	0.000157	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—kidney cancer	3.39e-05	0.000156	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—kidney cancer	3.3e-05	0.000152	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—kidney cancer	3.28e-05	0.000151	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—kidney cancer	3.28e-05	0.000151	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—kidney cancer	3.06e-05	0.000141	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—kidney cancer	2.98e-05	0.000137	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—kidney cancer	2.94e-05	0.000135	CcSEcCtD
Hydromorphone—Morphine—ABCB1—kidney cancer	2.92e-05	0.215	CrCbGaD
Hydromorphone—Diarrhoea—Doxorubicin—kidney cancer	2.84e-05	0.000131	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—kidney cancer	2.74e-05	0.000126	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—kidney cancer	2.64e-05	0.000121	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—kidney cancer	2.62e-05	0.00012	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—kidney cancer	2.61e-05	0.00012	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—kidney cancer	2.6e-05	0.00012	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—kidney cancer	2.46e-05	0.000113	CcSEcCtD
Hydromorphone—Dextromethorphan—ABCB1—kidney cancer	2.45e-05	0.181	CrCbGaD
Hydromorphone—OPRK1—Signaling Pathways—FLT1—kidney cancer	1.32e-05	0.000514	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—SLC5A5—kidney cancer	1.32e-05	0.000513	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—FH—kidney cancer	1.31e-05	0.000512	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APRT—kidney cancer	1.31e-05	0.000512	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—POMC—kidney cancer	1.29e-05	0.000501	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.28e-05	0.0005	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—SLC2A1—kidney cancer	1.27e-05	0.000496	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.26e-05	0.000491	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ACHE—kidney cancer	1.25e-05	0.000486	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTT1—kidney cancer	1.25e-05	0.000486	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPC3—kidney cancer	1.25e-05	0.000485	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNA1—kidney cancer	1.25e-05	0.000485	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—POMC—kidney cancer	1.24e-05	0.000484	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EIF4EBP1—kidney cancer	1.24e-05	0.000482	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HSPB1—kidney cancer	1.24e-05	0.000482	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPC3—kidney cancer	1.24e-05	0.000481	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.24e-05	0.000481	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JUNB—kidney cancer	1.22e-05	0.000476	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PAK1—kidney cancer	1.22e-05	0.000476	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CA2—kidney cancer	1.21e-05	0.000472	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CA2—kidney cancer	1.2e-05	0.000468	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—SCARB1—kidney cancer	1.18e-05	0.00046	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALAD—kidney cancer	1.18e-05	0.00046	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALAD—kidney cancer	1.17e-05	0.000456	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.15e-05	0.000449	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PSMD7—kidney cancer	1.15e-05	0.000448	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ANXA1—kidney cancer	1.15e-05	0.000448	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TSC1—kidney cancer	1.15e-05	0.000448	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PSMD7—kidney cancer	1.15e-05	0.000447	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PDHB—kidney cancer	1.14e-05	0.000445	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.14e-05	0.000445	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IGF2—kidney cancer	1.14e-05	0.000444	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.14e-05	0.000444	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN2B—kidney cancer	1.14e-05	0.000442	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—POMC—kidney cancer	1.13e-05	0.00044	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.13e-05	0.000439	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.12e-05	0.000435	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FLT1—kidney cancer	1.11e-05	0.000434	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IGF1R—kidney cancer	1.1e-05	0.000429	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—BCHE—kidney cancer	1.09e-05	0.000424	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PGK1—kidney cancer	1.08e-05	0.000421	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.08e-05	0.000421	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.08e-05	0.000419	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.08e-05	0.000419	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—SLC5A5—kidney cancer	1.07e-05	0.000418	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.07e-05	0.000417	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PGK1—kidney cancer	1.07e-05	0.000417	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—RAF1—kidney cancer	1.06e-05	0.000413	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTP1—kidney cancer	1.06e-05	0.000413	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LDHB—kidney cancer	1.06e-05	0.000412	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—POMC—kidney cancer	1.05e-05	0.000409	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LDHB—kidney cancer	1.05e-05	0.000409	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL2—kidney cancer	1.05e-05	0.000408	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—SLC2A1—kidney cancer	1.04e-05	0.000404	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PAK1—kidney cancer	1.03e-05	0.000402	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JUNB—kidney cancer	1.03e-05	0.000402	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.01e-05	0.000392	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ABCB1—kidney cancer	1.01e-05	0.000391	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF2—kidney cancer	1e-05	0.000389	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN2B—kidney cancer	9.95e-06	0.000387	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTM1—kidney cancer	9.76e-06	0.00038	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF1R—kidney cancer	9.67e-06	0.000376	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—POMC—kidney cancer	9.55e-06	0.000372	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL2—kidney cancer	9.52e-06	0.000371	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.32e-06	0.000363	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPAT—kidney cancer	9.32e-06	0.000363	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—RAF1—kidney cancer	9.31e-06	0.000363	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP1A1—kidney cancer	9.25e-06	0.00036	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2—kidney cancer	9.2e-06	0.000358	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CA9—kidney cancer	9.19e-06	0.000358	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CA9—kidney cancer	9.11e-06	0.000355	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HIF1A—kidney cancer	9.07e-06	0.000353	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TSC2—kidney cancer	9.05e-06	0.000352	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.9e-06	0.000347	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.78e-06	0.000342	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KDR—kidney cancer	8.68e-06	0.000338	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—FH—kidney cancer	8.67e-06	0.000337	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APRT—kidney cancer	8.67e-06	0.000337	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTP1—kidney cancer	8.66e-06	0.000337	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF2—kidney cancer	8.45e-06	0.000329	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	8.41e-06	0.000327	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2—kidney cancer	8.35e-06	0.000325	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ABCB1—kidney cancer	8.19e-06	0.000319	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1R—kidney cancer	8.17e-06	0.000318	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPC3—kidney cancer	8.15e-06	0.000317	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KIT—kidney cancer	7.99e-06	0.000311	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—APC—kidney cancer	7.99e-06	0.000311	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HIF1A—kidney cancer	7.96e-06	0.00031	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTM1—kidney cancer	7.96e-06	0.00031	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TSC2—kidney cancer	7.94e-06	0.000309	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CA2—kidney cancer	7.93e-06	0.000309	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—RAF1—kidney cancer	7.87e-06	0.000306	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CRABP1—kidney cancer	7.81e-06	0.000304	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2—kidney cancer	7.77e-06	0.000303	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CRABP1—kidney cancer	7.74e-06	0.000301	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALAD—kidney cancer	7.72e-06	0.000301	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	7.66e-06	0.000298	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KDR—kidney cancer	7.61e-06	0.000296	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—POMC—kidney cancer	7.61e-06	0.000296	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.6e-06	0.000296	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP1A1—kidney cancer	7.54e-06	0.000294	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.54e-06	0.000293	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—BRAF—kidney cancer	7.51e-06	0.000293	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.37e-06	0.000287	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	7.29e-06	0.000284	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ITPR2—kidney cancer	7.26e-06	0.000283	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ITPR2—kidney cancer	7.2e-06	0.00028	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PGK1—kidney cancer	7.06e-06	0.000275	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.06e-06	0.000275	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—kidney cancer	7.06e-06	0.000275	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—APC—kidney cancer	7.01e-06	0.000273	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KIT—kidney cancer	7.01e-06	0.000273	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	6.96e-06	0.000271	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LDHB—kidney cancer	6.93e-06	0.00027	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—POMC—kidney cancer	6.9e-06	0.000268	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—KRAS—kidney cancer	6.88e-06	0.000268	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HIF1A—kidney cancer	6.73e-06	0.000262	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	6.71e-06	0.000261	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TSC2—kidney cancer	6.71e-06	0.000261	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—POMC—kidney cancer	6.67e-06	0.00026	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.64e-06	0.000258	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ACHE—kidney cancer	6.62e-06	0.000258	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTT1—kidney cancer	6.62e-06	0.000258	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—BRAF—kidney cancer	6.59e-06	0.000257	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ACHE—kidney cancer	6.57e-06	0.000256	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTT1—kidney cancer	6.57e-06	0.000256	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KDR—kidney cancer	6.43e-06	0.00025	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	6.39e-06	0.000249	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	6.32e-06	0.000246	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RAF1—kidney cancer	6.27e-06	0.000244	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SCARB1—kidney cancer	6.27e-06	0.000244	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RELA—kidney cancer	6.25e-06	0.000243	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SCARB1—kidney cancer	6.21e-06	0.000242	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ERBB2—kidney cancer	6.21e-06	0.000242	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS1—kidney cancer	6.21e-06	0.000242	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.2e-06	0.000241	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS1—kidney cancer	6.15e-06	0.000239	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MTOR—kidney cancer	6.13e-06	0.000238	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	6.1e-06	0.000238	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSMD7—kidney cancer	6.09e-06	0.000237	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—KRAS—kidney cancer	6.03e-06	0.000235	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSMD7—kidney cancer	6.03e-06	0.000235	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CA9—kidney cancer	6.01e-06	0.000234	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APC—kidney cancer	5.92e-06	0.000231	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KIT—kidney cancer	5.92e-06	0.000231	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—BCHE—kidney cancer	5.77e-06	0.000225	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	5.75e-06	0.000224	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—BCHE—kidney cancer	5.72e-06	0.000223	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC5A5—kidney cancer	5.7e-06	0.000222	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	5.67e-06	0.000221	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.65e-06	0.00022	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—POMC—kidney cancer	5.64e-06	0.00022	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—kidney cancer	5.63e-06	0.000219	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—POMC—kidney cancer	5.62e-06	0.000219	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BRAF—kidney cancer	5.57e-06	0.000217	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	5.54e-06	0.000216	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.5e-06	0.000214	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RAF1—kidney cancer	5.5e-06	0.000214	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—kidney cancer	5.5e-06	0.000214	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—kidney cancer	5.48e-06	0.000213	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RELA—kidney cancer	5.48e-06	0.000213	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JUN—kidney cancer	5.47e-06	0.000213	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.46e-06	0.000212	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ERBB2—kidney cancer	5.44e-06	0.000212	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	5.43e-06	0.000211	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	5.4e-06	0.00021	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MTOR—kidney cancer	5.37e-06	0.000209	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.29e-06	0.000206	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTEN—kidney cancer	5.29e-06	0.000206	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	5.16e-06	0.000201	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CRABP1—kidney cancer	5.11e-06	0.000199	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—KRAS—kidney cancer	5.1e-06	0.000199	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	5.04e-06	0.000196	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—kidney cancer	4.93e-06	0.000192	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—kidney cancer	4.81e-06	0.000187	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JUN—kidney cancer	4.8e-06	0.000187	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTEN—kidney cancer	4.8e-06	0.000187	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—kidney cancer	4.78e-06	0.000186	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	4.76e-06	0.000185	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ITPR2—kidney cancer	4.75e-06	0.000185	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	4.68e-06	0.000182	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RAF1—kidney cancer	4.65e-06	0.000181	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTEN—kidney cancer	4.64e-06	0.000181	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RELA—kidney cancer	4.63e-06	0.00018	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.62e-06	0.00018	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ERBB2—kidney cancer	4.6e-06	0.000179	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTP1—kidney cancer	4.59e-06	0.000179	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTP1—kidney cancer	4.55e-06	0.000177	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MTOR—kidney cancer	4.54e-06	0.000177	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK3—kidney cancer	4.52e-06	0.000176	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—kidney cancer	4.48e-06	0.000175	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—kidney cancer	4.4e-06	0.000171	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCB1—kidney cancer	4.35e-06	0.000169	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ACHE—kidney cancer	4.33e-06	0.000169	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTT1—kidney cancer	4.33e-06	0.000169	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCB1—kidney cancer	4.31e-06	0.000168	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK1—kidney cancer	4.3e-06	0.000168	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	4.26e-06	0.000166	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—kidney cancer	4.22e-06	0.000164	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—kidney cancer	4.19e-06	0.000163	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—kidney cancer	4.18e-06	0.000163	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—kidney cancer	4.17e-06	0.000162	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SCARB1—kidney cancer	4.1e-06	0.00016	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KRAS—kidney cancer	4.06e-06	0.000158	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—kidney cancer	4.06e-06	0.000158	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS1—kidney cancer	4.06e-06	0.000158	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JUN—kidney cancer	4.06e-06	0.000158	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	4.03e-06	0.000157	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1A1—kidney cancer	4e-06	0.000156	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSMD7—kidney cancer	3.98e-06	0.000155	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK3—kidney cancer	3.97e-06	0.000154	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.96e-06	0.000154	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTEN—kidney cancer	3.92e-06	0.000153	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTEN—kidney cancer	3.91e-06	0.000152	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—kidney cancer	3.86e-06	0.00015	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK1—kidney cancer	3.77e-06	0.000147	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—BCHE—kidney cancer	3.77e-06	0.000147	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	3.73e-06	0.000145	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.73e-06	0.000145	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—kidney cancer	3.61e-06	0.000141	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.6e-06	0.00014	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KRAS—kidney cancer	3.56e-06	0.000139	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—kidney cancer	3.54e-06	0.000138	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—kidney cancer	3.38e-06	0.000132	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK3—kidney cancer	3.35e-06	0.00013	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	3.27e-06	0.000127	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—kidney cancer	3.26e-06	0.000127	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.26e-06	0.000127	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK1—kidney cancer	3.19e-06	0.000124	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—kidney cancer	3.17e-06	0.000123	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KRAS—kidney cancer	3.01e-06	0.000117	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTP1—kidney cancer	3e-06	0.000117	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—POMC—kidney cancer	2.98e-06	0.000116	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—POMC—kidney cancer	2.96e-06	0.000115	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.84e-06	0.000111	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	2.77e-06	0.000108	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—kidney cancer	2.76e-06	0.000107	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.76e-06	0.000107	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—kidney cancer	2.68e-06	0.000104	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.61e-06	0.000102	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—kidney cancer	2.38e-06	9.26e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—kidney cancer	2.36e-06	9.18e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTEN—kidney cancer	2.07e-06	8.07e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTEN—kidney cancer	2.06e-06	8e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—POMC—kidney cancer	1.95e-06	7.59e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.55e-06	6.05e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.46e-06	5.7e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.45e-06	5.65e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTEN—kidney cancer	1.36e-06	5.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.57e-07	3.72e-05	CbGpPWpGaD
